ArticleEuropean journal of immunology2021

Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.

Cristina Belgiovine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.